PSPLX
Price
$7.00
Change
+$0.04 (+0.57%)
Updated
Jan 31 closing price
Net Assets
95.38M
USPSX
Price
$22.50
Change
+$0.07 (+0.31%)
Updated
Jan 31 closing price
Net Assets
9.11M
Ad is loading...

PSPLX vs USPSX

Header iconPSPLX vs USPSX Comparison
Open Charts PSPLX vs USPSXBanner chart's image
PIMCO StocksPLUS® Short I2
Price$7.00
Change+$0.04 (+0.57%)
VolumeN/A
Net Assets95.38M
ProFunds UltraShort NASDAQ-100 Svc
Price$22.50
Change+$0.07 (+0.31%)
VolumeN/A
Net Assets9.11M
PSPLX vs USPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PSPLX vs. USPSX commentary
Feb 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSPLX is a Hold and USPSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PSPLX has more cash in the bank: 95.4M vs. USPSX (9.11M). USPSX pays higher dividends than PSPLX: USPSX (5.65) vs PSPLX (0.00). PSPLX was incepted earlier than USPSX: PSPLX (15 years) vs USPSX (27 years). USPSX has a lower initial minimum investment than PSPLX: USPSX (15000) vs PSPLX (1000000). PSPLX annual gain was more profitable for investors over the last year : -12.64 vs. USPSX (-35.61). PSPLX return over 5 years is better than : -45.49 vs. USPSX (-93.07).
PSPLXUSPSXPSPLX / USPSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years27 years-
Gain YTD-1.966-3.74353%
Front LoadN/AN/A-
Min. Initial Investment1000000150006,667%
Min. Initial Investment IRAN/A15000-
Net Assets95.4M9.11M1,047%
Annual Yield % from dividends0.005.65-
Returns for 1 year-12.64-35.6135%
Returns for 3 years-15.44-63.5524%
Returns for 5 years-45.49-93.0749%
Returns for 10 years-65.89-99.0966%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRON1.930.05
+2.66%
Cronos Group
ASX10.080.25
+2.54%
ASE Technology Holding Co Ltd
GME27.990.48
+1.74%
GameStop Corp
CARA5.010.02
+0.40%
Cara Therapeutics Inc
CTRN26.17-0.22
-0.83%
Citi Trends